Suppr超能文献

胆汁酸胆酸盐对人碳酸酐酶II激素抑制机制的结构解析

Structural elucidation of the hormonal inhibition mechanism of the bile acid cholate on human carbonic anhydrase II.

作者信息

Boone Christopher D, Tu Chingkuang, McKenna Robert

机构信息

Department of Biochemistry and Molecular Biology, University of Florida, PO Box 100267, Gainesville, FL 32610, USA.

Department of Pharmacology and Therapeutics, University of Florida, PO Box 100245, Gainesville, FL 32610, USA.

出版信息

Acta Crystallogr D Biol Crystallogr. 2014 Jun;70(Pt 6):1758-63. doi: 10.1107/S1399004714007457. Epub 2014 May 30.

Abstract

The carbonic anhydrases (CAs) are a family of mostly zinc metalloenzymes that catalyze the reversible hydration/dehydration of CO2 into bicarbonate and a proton. Human isoform CA II (HCA II) is abundant in the surface epithelial cells of the gastric mucosa, where it serves an important role in cytoprotection through bicarbonate secretion. Physiological inhibition of HCA II via the bile acids contributes to mucosal injury in ulcerogenic conditions. This study details the weak biophysical interactions associated with the binding of a primary bile acid, cholate, to HCA II. The X-ray crystallographic structure determined to 1.54 Å resolution revealed that cholate does not make any direct hydrogen-bond interactions with HCA II, but instead reconfigures the well ordered water network within the active site to promote indirect binding to the enzyme. Structural knowledge of the binding interactions of this nonsulfur-containing inhibitor with HCA II could provide the template design for high-affinity, isoform-specific therapeutic agents for a variety of diseases/pathological states, including cancer, glaucoma, epilepsy and osteoporosis.

摘要

碳酸酐酶(CAs)是一类主要的锌金属酶家族,可催化二氧化碳可逆地水合/脱水生成碳酸氢根和一个质子。人同工型CA II(HCA II)在胃黏膜表面上皮细胞中含量丰富,通过分泌碳酸氢根在细胞保护中发挥重要作用。在致溃疡情况下,胆汁酸对HCA II的生理抑制作用会导致黏膜损伤。本研究详细阐述了与初级胆汁酸胆酸盐与HCA II结合相关的微弱生物物理相互作用。以1.54 Å分辨率测定的X射线晶体结构表明,胆酸盐与HCA II没有直接的氢键相互作用,而是重新构建了活性位点内有序的水网络,以促进与酶的间接结合。这种不含硫的抑制剂与HCA II结合相互作用的结构知识可为多种疾病/病理状态(包括癌症、青光眼、癫痫和骨质疏松症)的高亲和力、同工型特异性治疗药物提供模板设计。

相似文献

8
Production and X-ray crystallographic analysis of fully deuterated human carbonic anhydrase II.全氘代人碳酸酐酶II的制备及X射线晶体学分析。
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 Jan 1;62(Pt 1):6-9. doi: 10.1107/S1744309105038248. Epub 2005 Dec 16.
9
Structure of bovine carbonic anhydrase II at 1.95 A resolution.分辨率为1.95埃的牛碳酸酐酶II的结构。
Acta Crystallogr D Biol Crystallogr. 2004 Apr;60(Pt 4):792-5. doi: 10.1107/S0907444904003166. Epub 2004 Mar 23.

引用本文的文献

3
Ibuprofen: a weak inhibitor of carbonic anhydrase II.布洛芬:碳酸酐酶 II 的弱抑制剂。
Acta Crystallogr F Struct Biol Commun. 2022 Nov 1;78(Pt 11):395-402. doi: 10.1107/S2053230X22009761. Epub 2022 Oct 14.
4
Carbonic Anhydrases II, IX, and XII in Reflux Esophagitis.碳酸酐酶 II、IX 和 XII 与反流性食管炎。
Dig Dis Sci. 2022 May;67(5):1761-1772. doi: 10.1007/s10620-021-06985-5. Epub 2021 Apr 30.
6
Carbonic anhydrase II in complex with carboxylic acid-based inhibitors.与基于羧酸的抑制剂结合的碳酸酐酶II
Acta Crystallogr F Struct Biol Commun. 2019 Mar 1;75(Pt 3):166-170. doi: 10.1107/S2053230X18018344. Epub 2019 Feb 20.

本文引用的文献

2
Insights towards sulfonamide drug specificity in α-carbonic anhydrases.探索磺酰胺类药物在α-碳酸酐酶中的特异性。
Bioorg Med Chem. 2013 Mar 15;21(6):1526-33. doi: 10.1016/j.bmc.2012.08.019. Epub 2012 Aug 28.
5
Towards automated crystallographic structure refinement with phenix.refine.利用phenix.refine实现自动化晶体学结构精修
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67. doi: 10.1107/S0907444912001308. Epub 2012 Mar 16.
6
MolProbity: all-atom structure validation for macromolecular crystallography.MolProbity:用于大分子晶体学的全原子结构验证
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21. doi: 10.1107/S0907444909042073. Epub 2009 Dec 21.
10
Phaser crystallographic software.相位结晶学软件。
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674. doi: 10.1107/S0021889807021206. Epub 2007 Jul 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验